{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:05:16Z","timestamp":1792073116872,"version":"4.4.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":1940,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Mesenchymal stem cells (MSCs) may have potential applications in regenerative medicine for the treatment of chronic liver diseases (CLDs). Human menstrual blood is a novel source of MSCs, termed menstrual blood-derived stem cells (MenSCs). Compared with bone marrow MSCs, MenSCs exhibit a higher proliferation rate and they can be obtained through a simple, safe, painless procedure without ethical concerns. Although the therapeutic efficacy of MenSCs has been explored in some diseases, their effects on liver fibrosis are still unclear. In the present study, we investigated the therapeutic effects of MenSC transplantation in a carbon tetrachloride-induced mouse model of liver fibrosis. These results revealed that MenSCs markedly improved liver function, attenuated collagen deposition, and inhibited activated hepatic stellate cells up to 2 weeks after transplantation. Moreover, tracking of green fluorescent protein-expressing MenSCs demonstrated that transplanted cells migrated to the sites of injury, but few differentiated into functional hepatocyte-like cells. Transwell coculturing experiments also showed that MenSCs suppressed proliferation of LX-2 cells (an immortalized hepatic stellate cell line) through secretion of monocyte chemoattractant protein-1, interleukin-6, hepatocyte growth factor, growth-related oncogene, interleukin-8, and osteoprotegerin. Collectively, our results provided preliminary evidence for the antifibrotic capacity of MenSCs in liver fibrosis and suggested that these cells may be an alternative therapeutic approach for the treatment of CLDs.<\/jats:p>","DOI":"10.5966\/sctm.2015-0265","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T02:58:21Z","timestamp":1469761101000},"page":"272-284","source":"Crossref","is-referenced-by-count":112,"title":["Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators"],"prefix":"10.1093","volume":"6","author":[{"given":"Lijun","family":"Chen","sequence":"first","affiliation":[{"name":"a Institute of Cell and Development, College of Life Sciences, Zhejiang University, Hangzhou, People's Republic of China"},{"name":"b State Key Laboratory for Diagnosis and Treatment of Infectious Diseases and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China"},{"name":"c Molecular Diagnosis Division, Zhejiang-California International Nanosystem Institute, Zhejiang University, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"a Institute of Cell and Development, College of Life Sciences, Zhejiang University, Hangzhou, People's Republic of China"},{"name":"b State Key Laboratory for Diagnosis and Treatment of Infectious Diseases and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China"},{"name":"c Molecular Diagnosis Division, Zhejiang-California International Nanosystem Institute, Zhejiang University, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[{"name":"b State Key Laboratory for Diagnosis and Treatment of Infectious Diseases and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Wang","sequence":"additional","affiliation":[{"name":"b State Key Laboratory for Diagnosis and Treatment of Infectious Diseases and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Xiang","sequence":"additional","affiliation":[{"name":"b State Key Laboratory for Diagnosis and Treatment of Infectious Diseases and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxing","family":"Wu","sequence":"additional","affiliation":[{"name":"a Institute of Cell and Development, College of Life Sciences, Zhejiang University, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Guo","sequence":"additional","affiliation":[{"name":"b State Key Laboratory for Diagnosis and Treatment of Infectious Diseases and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhou","family":"Mou","sequence":"additional","affiliation":[{"name":"d Clinical Research Institute, Zhejiang Provincial People's Hospital, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yuan","sequence":"additional","affiliation":[{"name":"b State Key Laboratory for Diagnosis and Treatment of Infectious Diseases and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[{"name":"b State Key Laboratory for Diagnosis and Treatment of Infectious Diseases and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfu","family":"Wang","sequence":"additional","affiliation":[{"name":"a Institute of Cell and Development, College of Life Sciences, Zhejiang University, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie","family":"Xiang","sequence":"additional","affiliation":[{"name":"b State Key Laboratory for Diagnosis and Treatment of Infectious Diseases and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China"},{"name":"c Molecular Diagnosis Division, Zhejiang-California International Nanosystem Institute, Zhejiang University, Hangzhou, People's Republic of China"},{"name":"e Institute for Cell-Based Drug Development of Zhejiang Province, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,7,28]]},"reference":[{"key":"2022022809213500000_R1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"2022022809213500000_R2","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: Therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"2022022809213500000_R3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"2022022809213500000_R4","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J Clin Invest"},{"key":"2022022809213500000_R5","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/stem.1818","article-title":"Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis","volume":"32","author":"Volarevic","year":"2014","journal-title":"STEM CELLS"},{"key":"2022022809213500000_R6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5966\/sctm.2014-0276","article-title":"Proceedings: Moving toward cell-based therapies for liver disease","volume":"4","author":"Kadyk","year":"2015","journal-title":"STEM CELLS TRANSLATIONAL MEDICINE"},{"key":"2022022809213500000_R7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jhep.2013.01.018","article-title":"Stem cell therapies for liver failure and cirrhosis","volume":"59","author":"Zhang","year":"2013","journal-title":"J Hepatol"},{"key":"2022022809213500000_R8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5966\/sctm.2011-0019","article-title":"Concise review: Mesenchymal stem cells and translational medicine: Emerging issues","volume":"1","author":"Ren","year":"2012","journal-title":"STEM CELLS TRANSLATIONAL MEDICINE"},{"key":"2022022809213500000_R9","doi-asserted-by":"crossref","first-page":"12340","DOI":"10.1074\/jbc.M110.194498","article-title":"Delta-like 1 serves as a new target and contributor to liver fibrosis down-regulated by mesenchymal stem cell transplantation","volume":"286","author":"Pan","year":"2011","journal-title":"J Biol Chem"},{"key":"2022022809213500000_R10","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/hep.26135","article-title":"Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis","volume":"57","author":"Huang","year":"2013","journal-title":"Hepatology"},{"key":"2022022809213500000_R11","doi-asserted-by":"crossref","first-page":"e43408","DOI":"10.1371\/journal.pone.0043408","article-title":"HGF and direct mesenchymal stem cells contact synergize to inhibit hepatic stellate cells activation through TLR4\/NF-kB pathway","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"2022022809213500000_R12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.lfs.2009.08.003","article-title":"Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis","volume":"85","author":"Chang","year":"2009","journal-title":"Life Sci"},{"key":"2022022809213500000_R13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2014.10.030","article-title":"Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice","volume":"62","author":"Meier","year":"2015","journal-title":"J Hepatol"},{"key":"2022022809213500000_R14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/jcmm.12482","article-title":"The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases","volume":"19","author":"Liu","year":"2015","journal-title":"J Cell Mol Med"},{"key":"2022022809213500000_R15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1479-5876-10-133","article-title":"Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats","volume":"10","author":"Wang","year":"2012","journal-title":"J Transl Med"},{"key":"2022022809213500000_R16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.scr.2013.07.003","article-title":"Efficacy of adipose tissue-mesenchymal stem cell transplantation in rats with acetaminophen liver injury","volume":"11","author":"Salomone","year":"2013","journal-title":"Stem Cell Res (Amst)"},{"key":"2022022809213500000_R17","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue","volume":"24","author":"Kern","year":"2006","journal-title":"STEM CELLS"},{"key":"2022022809213500000_R18","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/01.RES.0000265074.83288.09","article-title":"Adipose-derived stem cells for regenerative medicine","volume":"100","author":"Gimble","year":"2007","journal-title":"Circ Res"},{"key":"2022022809213500000_R19","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.scr.2013.08.011","article-title":"Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence?","volume":"11","author":"Meier","year":"2013","journal-title":"Stem Cell Res (Amst)"},{"key":"2022022809213500000_R20","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1053\/j.gastro.2008.05.040","article-title":"Critical review of clinical trials of bone marrow stem cells in liver disease","volume":"135","author":"Houlihan","year":"2008","journal-title":"Gastroenterology"},{"key":"2022022809213500000_R21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/gut.2006.111617","article-title":"Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: Engraftment and hepatocyte differentiation versus profibrogenic potential","volume":"57","author":"di Bonzo","year":"2008","journal-title":"Gut"},{"key":"2022022809213500000_R22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1479-5876-5-57","article-title":"Endometrial regenerative cells: A novel stem cell population","volume":"5","author":"Meng","year":"2007","journal-title":"J Transl Med"},{"key":"2022022809213500000_R23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1631\/jzus.B1200062","article-title":"Human adult stem cells from menstrual blood and endometrial tissue","volume":"13","author":"Allickson","year":"2012","journal-title":"J Zhejiang Univ Sci B"},{"key":"2022022809213500000_R24","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1038\/srep04599","article-title":"Derivation of human decidua-like cells from amnion and menstrual blood","volume":"4","author":"Sugawara","year":"2014","journal-title":"Sci Rep"},{"key":"2022022809213500000_R25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13287-015-0013-5","article-title":"Characterization of menstrual stem cells: Angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells","volume":"6","author":"Alcayaga-Miranda","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"2022022809213500000_R26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/molehr\/gaq061","article-title":"Adult stem cells in the endometrium","volume":"16","author":"Gargett","year":"2010","journal-title":"Mol Hum Reprod"},{"key":"2022022809213500000_R27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fimmu.2014.00205","article-title":"The promising potential of menstrual stem cells for antenatal diagnosis and cell therapy","volume":"5","author":"Khoury","year":"2014","journal-title":"Front Immunol"},{"key":"2022022809213500000_R28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/molehr\/gau044","article-title":"Menstrual blood-derived stromal stem cells from women with and without endometriosis reveal different phenotypic and functional characteristics","volume":"20","author":"Nikoo","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"2022022809213500000_R29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1631\/jzus.B1100015","article-title":"Plasticity of human menstrual blood stem cells derived from the endometrium","volume":"12","author":"Lin","year":"2011","journal-title":"J Zhejiang Univ Sci B"},{"key":"2022022809213500000_R30","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/jcmm.12100","article-title":"Human endometrial stem cells confer enhanced myocardial salvage and regeneration by paracrine mechanisms","volume":"17","author":"Jiang","year":"2013","journal-title":"J Cell Mol Med"},{"key":"2022022809213500000_R31","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1089\/scd.2013.0390","article-title":"Transplantation of human menstrual blood progenitor cells improves hyperglycemia by promoting endogenous progenitor differentiation in type 1 diabetic mice","volume":"23","author":"Wu","year":"2014","journal-title":"Stem Cells Dev"},{"key":"2022022809213500000_R32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1479-5876-7-15","article-title":"Feasibility investigation of allogeneic endometrial regenerative cells","volume":"7","author":"Zhong","year":"2009","journal-title":"J Transl Med"},{"key":"2022022809213500000_R33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/scd.2009.0340","article-title":"Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke","volume":"19","author":"Borlongan","year":"2010","journal-title":"Stem Cells Dev"},{"key":"2022022809213500000_R34","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1089\/scd.2013.0371","article-title":"Transplantation of human menstrual blood stem cells to treat premature ovarian failure in mouse model","volume":"23","author":"Liu","year":"2014","journal-title":"Stem Cells Dev"},{"key":"2022022809213500000_R35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neubiorev.2011.05.010","article-title":"Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke","volume":"36","author":"Rodrigues","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"2022022809213500000_R36","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.ijcard.2013.03.126","article-title":"Menstrual blood derived mesenchymal cells ameliorate cardiac fibrosis via inhibition of endothelial to mesenchymal transition in myocardial infarction","volume":"168","author":"Zhang","year":"2013","journal-title":"Int J Cardiol"},{"key":"2022022809213500000_R37","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/mt.2011.173","article-title":"Derivation of insulin producing cells from human endometrial stromal stem cells and use in the treatment of murine diabetes","volume":"19","author":"Santamaria","year":"2011","journal-title":"Mol Ther"},{"key":"2022022809213500000_R38","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1091\/mbc.e06-09-0872","article-title":"Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation","volume":"18","author":"Cui","year":"2007","journal-title":"Mol Biol Cell"},{"key":"2022022809213500000_R39","doi-asserted-by":"crossref","first-page":"E124","DOI":"10.1002\/term.1715","article-title":"Efficient generation of functional hepatocyte-like cells from menstrual blood-derived stem cells","volume":"9","author":"Khanjani","year":"2015","journal-title":"J Tissue Eng Regen Med"},{"key":"2022022809213500000_R40","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1631\/jzus.B1300081","article-title":"Menstrual blood-derived mesenchymal stem cells differentiate into functional hepatocyte-like cells","volume":"14","author":"Mou","year":"2013","journal-title":"J Zhejiang Univ Sci B"},{"key":"2022022809213500000_R41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: New tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"2022022809213500000_R42","doi-asserted-by":"crossref","first-page":"e42182","DOI":"10.1371\/journal.pone.0042182","article-title":"Functional characterizations of RIG-I to GCRV and viral\/bacterial PAMPs in grass carp Ctenopharyngodon idella","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"2022022809213500000_R43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1577","article-title":"TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation","volume":"9","author":"Shi","year":"2008","journal-title":"Nat Immunol"},{"key":"2022022809213500000_R44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2022022809213500000_R45","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3748\/wjg.v21.i3.742","article-title":"Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects","volume":"21","author":"Berardis","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2022022809213500000_R46","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jhep.2011.09.021","article-title":"The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis","volume":"56","author":"Kisseleva","year":"2012","journal-title":"J Hepatol"},{"key":"2022022809213500000_R47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","article-title":"Stem cell therapies in clinical trials: Progress and challenges","volume":"17","author":"Trounson","year":"2015","journal-title":"Cell Stem Cell"},{"key":"2022022809213500000_R48","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5966\/sctm.2013-0196","article-title":"Concise review: Optimizing expansion of bone marrow mesenchymal stem\/stromal cells for clinical applications","volume":"3","author":"Hoch","year":"2014","journal-title":"STEM CELLS TRANSLATIONAL MEDICINE"},{"key":"2022022809213500000_R49","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jhep.2009.01.028","article-title":"Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis","volume":"50","author":"Li","year":"2009","journal-title":"J Hepatol"},{"key":"2022022809213500000_R50","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1634\/stemcells.2007-0941","article-title":"Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury","volume":"26","author":"Carvalho","year":"2008","journal-title":"STEM CELLS"},{"key":"2022022809213500000_R51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.abb.2014.02.015","article-title":"Cellular and molecular mechanisms in liver fibrogenesis","volume":"548","author":"Novo","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"2022022809213500000_R52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.it.2011.11.004","article-title":"How mesenchymal stem cells interact with tissue immune responses","volume":"33","author":"Shi","year":"2012","journal-title":"Trends Immunol"},{"key":"2022022809213500000_R53","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat Commun"},{"key":"2022022809213500000_R54","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/cphy.c120035","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr Physiol"},{"key":"2022022809213500000_R55","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-\u03b2 in progression of liver disease","volume":"347","author":"Dooley","year":"2012","journal-title":"Cell Tissue Res"},{"key":"2022022809213500000_R56","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2007.05.150","article-title":"Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells","volume":"363","author":"Parekkadan","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"2022022809213500000_R57","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.lfs.2009.06.007","article-title":"Nerve growth factor-mediated paracrine regulation of hepatic stellate cells by multipotent mesenchymal stromal cells","volume":"85","author":"Lin","year":"2009","journal-title":"Life Sci"},{"key":"2022022809213500000_R58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/cmi.2011.53","article-title":"Liver fibrosis: Mechanisms of immune-mediated liver injury","volume":"9","author":"Xu","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"2022022809213500000_R59","first-page":"297","article-title":"Interleukins in chronic liver disease: Lessons learned from experimental mouse models","volume":"7","author":"Hammerich","year":"2014","journal-title":"Clin Exp Gastroenterol"},{"key":"2022022809213500000_R60","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/path.2453","article-title":"Stem cells in liver regeneration, fibrosis and cancer: The good, the bad and the ugly","volume":"217","author":"Alison","year":"2009","journal-title":"J Pathol"},{"key":"2022022809213500000_R61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.onc.1205016","article-title":"Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: Involvement of induction of Bcl-2 and Bcl-x(L) proteins","volume":"21","author":"Hong","year":"2002","journal-title":"Oncogene"},{"key":"2022022809213500000_R62","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","author":"Baeck","year":"2012","journal-title":"Gut"},{"key":"2022022809213500000_R63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.22952","article-title":"CCR2 promotes hepatic fibrosis in mice","volume":"50","author":"Seki","year":"2009","journal-title":"Hepatology"},{"key":"2022022809213500000_R64","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1038\/emm.2014.49","article-title":"Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis","volume":"46","author":"Kim","year":"2014","journal-title":"Exp Mol Med"},{"key":"2022022809213500000_R65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1479-5876-11-78","article-title":"Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice","volume":"11","author":"Nasir","year":"2013","journal-title":"J Transl Med"},{"key":"2022022809213500000_R66","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"key":"2022022809213500000_R67","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1074\/jbc.M113.491589","article-title":"Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H\/E195R to osteoprotegerin (OPG) overcomes TRAIL resistance mediated by the bone microenvironment","volume":"289","author":"Bosman","year":"2014","journal-title":"J Biol Chem"},{"key":"2022022809213500000_R68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"2022022809213500000_R69","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/stem.1461","article-title":"Reversing bone loss by directing mesenchymal stem cells to bone","volume":"31","author":"Yao","year":"2013","journal-title":"STEM CELLS"},{"key":"2022022809213500000_R70","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nm.2665","article-title":"Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass","volume":"18","author":"Guan","year":"2012","journal-title":"Nat Med"},{"key":"2022022809213500000_R71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10238-012-0218-1","article-title":"Therapeutic application of mesenchymal stem cells in bone and joint diseases","volume":"14","author":"Liu","year":"2014","journal-title":"Clin Exp Med"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2015-0265","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/6\/1\/272\/42632505\/stcltm_6_1_272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/6\/1\/272\/42632505\/stcltm_6_1_272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T09:27:19Z","timestamp":1646040439000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/6\/1\/272\/6404698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,28]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,7,28]]},"published-print":{"date-parts":[[2017,1,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2015-0265","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,1,1]]},"published":{"date-parts":[[2016,7,28]]}}}